• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients

tetano

Editor, Senior Moderator
J Clin Med


. 2021 May 8;10(9):2017.
doi: 10.3390/jcm10092017.
HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients


Álvaro Tamayo-Velasco[SUP] 1 [/SUP], Pedro Martínez-Paz[SUP] 2 3 [/SUP], María Jesús Peñarrubia-Ponce[SUP] 1 [/SUP], Ignacio de la Fuente[SUP] 1 [/SUP], Sonia Pérez-González[SUP] 1 [/SUP], Itziar Fernández[SUP] 4 [/SUP], Carlos Dueñas[SUP] 5 [/SUP], Esther Gómez-Sánchez[SUP] 2 3 6 [/SUP], Mario Lorenzo-López[SUP] 2 3 6 [/SUP], Estefanía Gómez-Pesquera[SUP] 2 3 6 [/SUP], María Heredia-Rodríguez[SUP] 2 3 7 [/SUP], Irene Carnicero-Frutos[SUP] 8 9 [/SUP], María Fe Muñoz-Moreno[SUP] 8 [/SUP], David Bernardo[SUP] 10 [/SUP], Francisco Javier Álvarez[SUP] 3 11 [/SUP], Eduardo Tamayo[SUP] 2 3 6 [/SUP], Hugo Gonzalo-Benito[SUP] 3 8 9 [/SUP]



Affiliations
Free article

Abstract

Pneumonia is the leading cause of hospital admission and mortality in coronavirus disease 2019 (COVID-19). We aimed to identify the cytokines responsible for lung damage and mortality. We prospectively recruited 108 COVID-19 patients between March and April 2020 and divided them into four groups according to the severity of respiratory symptoms. Twenty-eight healthy volunteers were used for normalization of the results. Multiple cytokines showed statistically significant differences between mild and critical patients. High HGF levels were associated with the critical group (OR = 3.51; p < 0.001; 95%CI = 1.95-6.33). Moreover, high IL-1α (OR = 1.36; p = 0.01; 95%CI = 1.07-1.73) and low IL-27 (OR = 0.58; p < 0.005; 95%CI = 0.39-0.85) greatly increased the risk of ending up in the severe group. This model was especially sensitive in order to predict critical status (AUC = 0.794; specificity = 69.74%; sensitivity = 81.25%). Furthermore, high levels of HGF and IL-1α showed significant results in the survival analysis (p = 0.033 and p = 0.011, respectively). HGF, IL-1α, and IL 27 at hospital admission were strongly associated with severe/critical COVID-19 patients and therefore are excellent predictors of bad prognosis. HGF and IL-1α were also mortality biomarkers.

Keywords: coronavirus disease 2019; cytokines; mortality; prognosis; severity.
 
Back
Top Bottom